INTRAOSSEOUS INFUSI

The contract involves the procurement of two packages of Intraosseous Infusion System EZ-IO 45 mm kits, each package containing five units, for a total of ten kits. Each kit includes a 15-gauge sterile EZ-IO needle, EZ-stabilizer dressing, EZ-connect extension set, Needlevise 1-port sharps block, and a patient wristband, designed to streamline and secure intraosseous vascular access with improved adhesion, reduced risk of dislodgement, and full visibility of the insertion site. The items must have a 48-month shelf life from manufacture, with no more than seven months elapsed between manufacturing and government delivery. Packaging and labeling must strictly comply with DLA Master List of Technical and Quality Requirements, ASTM D3951, MIL-STD-129, and RP001 DLA Packaging Requirements, including proper markings for NSN 6515-01-646-9750, contract number, quantity per unit pack, and machine-readable 2D Data Matrix barcodes. Delivery is required at FOB Destination within 20 days of award, with inspection and acceptance performed by the government at the delivery location. The contract is a Firm Fixed Price acquisition under simplified procedures, managed via DIBBS, with a total value of $1,444.00 and no option quantities or term extensions. Contractors must comply with federal cybersecurity mandates including NIST SP 800-171, safeguarding covered defense information, reporting cyber incidents, and avoiding prohibited telecommunications equipment under DFARS clauses. They must also submit NIST assessment results via the Supplier Performance Risk System, disclose UEI and CAGE codes, represent small business status if applicable, and certify compliance with whistleblower rights, trafficking in persons prohibitions, and other regulatory requirements. All supplies must be sourced, labeled, and documented precisely to meet DLA and DoD standards for medical devices and supply chain integrity.